Login

Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results 00:00:00

Share On Facebook Share On Twitter

Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
build our financial infrastructure using software|Seth Rosenberg,Investor,Greylock
00:10:00
"Embark on an insightful journey with John Lai, the dynamic CEO & President of PetVivo Holdings, Inc., as he unveils the company's visionary roadmap in a groundbreaking interview."|Mr. Lai has been a director and senior executive officer of PetVivo Holdin
00:10:00
Dale Tsai, General Manager of the United States|CEO, AOPEN Inc
00:10:00
Addressing Climate Risks and Opportunities in the Mining Industry
00:10:00
Joel Greenblatt, co-chief investment officer and managing principal at Gotham Asset Management, defines value investing as buying assets for less than their intrinsic value, aiming for long-term appreciation.|Joel Greenblatt, co-chief investment officer a
00:10:00
Alaska Airlines CEO Ben Minicucci on the Future of Aviation | Ben Minicucci, CEO, Alaska Airlines .
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Weijian Shan on Transforming Shenzhen Development Bank and His Journey from Barefoot Doctor to Finance Leader Part-1 | Weijian Shan, CEO, PAG.
00:10:00
The company's IPO on the NYSE and its future prospects in technology and business expansion | Alice Chang, CEO, Perfect Corp.
00:00:00
Robotic-assisted kidney transplant -Patrick G. Dean, M.D. Transplant Surgeon, Mayo Clinic
00:10:00
RCR CEO Jericho Go on Driving Growth and Expanding Market Leadership | Jericho Go, CEO, RL Commercial REIT.
00:10:00
Fidelity Asia Fund Update: Gary Monaghan and Anthony Srom Discuss Market Sentiment and Investment Strategy | Gary Monaghan - Anthony Srom, Fidelity International

© 2017 - Neuhu+